No products in the cart.
All Antibodies Approved or in Clinical Trials ichorbio has created an editable spreadsheet that we [...]
Non-small cell lung cancer (NSCLC) is the most common lung cancer. There are three main [...]
Psoriasis is a skin disease that causes red, itchy scaly patches, most commonly on the [...]
ichorbio has created a document on how to write a great life science paper which [...]
ichorbio is pleased to release our new and updated flyer for all of our different [...]
ichorbio released a research grade (RUO) version of the biosimilar Durvalumab on 18th November 2021. [...]
ichorbio has released five new biosimilars targeting PD-1 and PD-L1. The biosimilars are as follows: [...]
Today, ichorbio is excited to announce the release of our second mouse anti-mouse recombinant antibody. [...]
Today, ichorbio is excited to announce the release of our first mouse anti-mouse recombinant antibody. [...]
ichorbio has released two new recombinant antibodies this month which are mouse anti-mouse versions of [...]
ichorbio has produced a flyer to showcase all of our biosimilars for research use only [...]
ichorbio has released 8 new products for August 2021, four bulk anti-human antibodies and six [...]
With the help of our partner, Binaree – ichorbio has been creating new immunofluorescence validation [...]
ichorbio has created a free to download PDF on ways to inject mice – click [...]
Username or email address *
Password *
Remember me Log in
Lost your password?
Email address *
A password will be sent to your email address.
Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy.
Register
Please share your location to continue.
Check our help guide for more info.
